IVI MEMBER SPOTLIGHT: The Assistance Fund
Over the summer, we sat down with Stephanie Marshall, Director of Advocacy from The Assistance Fund to learn more about the organization and their priorities for the future of value assessment. [...]
In Memoriam: Samuel Nussbaum, MD
The staff and volunteer leaders of the Innovation and Value Initiative (IVI) mourn the passing of Samuel Nussbaum, MD, on September 23, 2021. Dr. Nussbaum chaired the IVI Board of Directors since 2019 and was [...]
IVI Drug Pricing Proposal Statement
Jennifer Bright, Executive Director, Innovation and Value Initiative, issued the following statement on Biden Administration and Congressional Democrats drug pricing proposals. "While exercising government levers to address drug pricing and pricing transparency are needed, the [...]
IVI MEMBER SPOTLIGHT: Arthritis Foundation
IVI had a chance to sit down with Anna Hyde, Vice President of Advocacy and Access at the Arthritis Foundation to discuss the organization's goals and how they are getting involved with value [...]
Supporting Equity in Value Assessment
Author: Rick Chapman, PhD, Chief Science Officer, IVI How do we ensure that the data and methods used for value assessment adequately account for the diversity of patients and the urgent need to correct [...]
What Distinguishes IVI’s Approach to Value Assessment?
Author: Rick Chapman, PhD, Chief Science Officer, IVI Policymakers continue to grapple with finding the right approaches to curtailing drug costs and improving health care. Organizations that conduct value and health technology assessment (HTA) [...]
Toward Equity in Value Assessment: Paths Forward
Author: Jennifer Bright, MPA, Executive Director, IVI "Poor value assessment hardwires inequity into health." - Michelle McMurry-Heath, MD, PhD; Biotechnology Innovation Organization - Session 1: Meaningful Action Toward Health Equity IVI's three-part series on health [...]
Q&A with IVI’s Executive Director, Jennifer Bright
Ms. Bright brings over two decades of health care policy, issue management, patient advocacy, and executive leadership to the role. She is also founder and President of Momentum Health Strategies and has [...]
PRESS RELEASE: Exploring Patient-Driven Value Factors
Value Blueprints Research Brief Explores Patient-Driven Value Element Framework to Identify Factors Most Important to Patients Alexandria, VA — June 3, 2021 — The Innovation and Value Initiative (IVI), an independent, nonprofit research organization dedicated [...]
Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States
IVI economists and staff recently published this open-access article describing specifically how IVI puts stakeholder engagement at the center of value assessment. Read about the engagement process IVI is using to build patient-centricity into its [...]
Questions about the IVI-MDD Model Scope
On Monday, May 3, IVI, along with Jessica Kennedy from Mental Health America and Mohannad Kusti from Pivot Onsite-Innovations, held an informational webinar on the draft model scope for IVIs's upcoming economic model on major [...]
PRESS RELEASE: IVI to Hold Second Methods Summit to Drive Patient-Centered Value Assessment
Summit Will Address Priority Patient Inputs for Comparative Effectiveness Research and HTA Alexandria, VA — April 27, 2021 — The Innovation and Value Initiative (IVI), an independent nonprofit research organization dedicated to advancing patient-centric value [...]